Global Lung Cancer Surgery Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.biz delivers in-depth insights on the global lung cancer surgery market in its upcoming report titled, “Global Lung Cancer Surgery Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027”. The global lung cancer surgery market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global lung cancer surgery market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global lung cancer surgery market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global lung cancer surgery market report has been segmented on the basis device, procedure, and region.

Request Covid - 19 Impact

Lung cancer, also known as lung carcinoma, is a malignant lung tumour characterized by uncontrolled cell growth in tissues of the lung. Lung cancer primarily occurs in people with high nicotine intake, or people who smoke. The risk of lung cancer increases with time and also with number of cigarettes smoked by an individual. There are no particular signs or symptoms for lung cancer at its initial stage. Lung cancer occurs only when the disease has advanced to a certain stage.

Increasing incidence of lung cancer across the globe, coupled with high awareness levels among the general population about cancer treatment, and continuous developments in surgery equipment are key factors driving growth of the global lung cancer surgery market. In addition, introduction of advanced healthcare infrastructure, increasing number of cigarette smokers, and less amount of time required for lung cancer surgeries using new advanced technologies are all major factors expected to fuel growth to the global lung cancer surgery market over the forecast period.

However, high cost of lung cancer surgery is a key factor restraining growth of the global lung cancer surgery market. Additionally, lack of skilled professionals for lung cancer treatment, and lack of appropriate infrastructure in developing economies are major factors expected to restrain growth of the global lung cancer surgery market over the forecast period.

The market in North America accounted for highest revenue share in the global lung cancer surgery market, owing to presence of appropriate healthcare infrastructure, coupled with increasing incidence of lung cancer in the region. In addition, technological developments in surgical techniques is also expected to boost growth for the global lung cancer surgery market. The first robotic surgical system was used in Canada to treat early-stage lung cancer by removing the cancer, along with a lobe of the lung. The market in Asia Pacific is expected to expand with highest CAGR of X.X% over the forecast period. This can be attributed to increasing number of lung cancer patients, government initiatives in improving healthcare infrastructure, and high rate of cigarette consumption in the region.

Global Lung Cancer Surgery Market Segmentation:

Global lung cancer surgery market segmentation by device:

• Surgical instruments
• Monitoring and visualizing systems
• Endosurgical equipment

Global lung cancer surgery market segmentation by procedure:

• Robot assisted surgery
• Minimally invasive surgical procedure
• Percutaneous transcatheter surgery

Global lung cancer surgery market segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa